Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has particularly impacted patients with hemato-oncological malignancies, as they showed not only a higher propensity for severe courses but also weaker immune responses after vaccination. Still, data on the influen...

Descripción completa

Detalles Bibliográficos
Autores principales: Mair, M.J., Mitterer, M., Buratti, T., Berchtold, L., Fong, D., Preusser, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126224/
https://www.ncbi.nlm.nih.gov/pubmed/37196399
http://dx.doi.org/10.1016/j.esmoop.2023.101559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126224/
https://www.ncbi.nlm.nih.gov/pubmed/37196399
http://dx.doi.org/10.1016/j.esmoop.2023.101559

Ejemplares similares